2011
DOI: 10.1007/s12250-011-3184-y
|View full text |Cite
|
Sign up to set email alerts
|

Down-regulation of HIV-1 infection by inhibition of the MAPK signaling pathway

Abstract: The human immunodeficiency virus type 1 (HIV-1) can interact with and exploit the host cellular machinery to replicate and propagate itself. Numerous studies have shown that the Mitogen-activated protein kinase (MAPK) signal pathway can positively regulate the replication of HIV-1, but exactly how each MAPK pathway affects HIV-1 infection and replication is not understood. In this study, we used the Extracellular signal-regulated kinase (ERK) pathway inhibitor, PD98059, the Jun N-terminal kinase (JNK) pathway … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
17
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 28 publications
2
17
0
Order By: Relevance
“…These results suggested that MAPKs inhibitors, ERK, p38 and JNK, were involved in the microfilaments of IPEC-J2 cells. In addition, inhibition of MAPKs also decreased the PEDV and TGEV infection, which was consistent with the report that the effect of MAPK pathway inhibitors on HIV infection (Gong et al, 2011). However, the relationship between the PEDV and TGEV infection and MAPK pathway remains to be further investigated.…”
Section: Discussionsupporting
confidence: 90%
“…These results suggested that MAPKs inhibitors, ERK, p38 and JNK, were involved in the microfilaments of IPEC-J2 cells. In addition, inhibition of MAPKs also decreased the PEDV and TGEV infection, which was consistent with the report that the effect of MAPK pathway inhibitors on HIV infection (Gong et al, 2011). However, the relationship between the PEDV and TGEV infection and MAPK pathway remains to be further investigated.…”
Section: Discussionsupporting
confidence: 90%
“…Of these, the most extensive studies are ERK1/2, JNKs and p38 MAPKs. As previously reported, JNK1/2 and/or p38 MAPK pathways is required for infection and replication of human immunodeficiency virus type 1, encephalomyocarditis virus, coxsackievirus B3, hepatitis C virus, herpes simplex virus 1, and the severe acute respiratory syndrome coronavirus [13][14][15][16][17][18]. The diverse effects of JNK1/2 and p38 MAPK activation by these viruses include induction of apoptosis in infected cells and enhancement of viral replication.…”
mentioning
confidence: 65%
“…Potential anti-inflammatory compounds are also known to target different signaling pathways to attenuate the inflammatory response. In particular, MAPKs are widely known to be involved in various pathological processes associated with HIV-1 infection (such as neurotoxicity, macrophage activation, viral replication) [49]. Studies have further demonstrated that inhibition of these kinases can downregulate HIV-1 infection as well as decrease transcellular transport of HIV-1 across blood-brain barrier in vitro [49-51].…”
Section: Discussionmentioning
confidence: 99%
“…In particular, MAPKs are widely known to be involved in various pathological processes associated with HIV-1 infection (such as neurotoxicity, macrophage activation, viral replication) [49]. Studies have further demonstrated that inhibition of these kinases can downregulate HIV-1 infection as well as decrease transcellular transport of HIV-1 across blood-brain barrier in vitro [49-51]. Therefore, we examined these pathways in our gp120-associated brain inflammation model and observed activation of ERK1/2 and JNKs in the hippocampus.…”
Section: Discussionmentioning
confidence: 99%